Lipid profile, apolipoproteins A and B in children with epilepsy

Area of Science:

• Pediatric Neurology
• Clinical Biochemistry
• Cardiovascular Health

Background:

• Idiopathic epilepsy is a common neurological disorder in children.
• Antiepileptic drugs (AEDs) like carbamazepine and valproate are frequently prescribed.
• Potential long-term effects of AEDs on metabolic and cardiovascular health require investigation.

Purpose of the Study:

• To assess the impact of carbamazepine and valproate on lipid profiles in children with idiopathic epilepsy.
• To measure carotid artery intimal wall thickness in these children.
• To evaluate potential cardiovascular risks associated with these AEDs.

Main Methods:

• Lipid profiles (triglycerides, cholesterol subfractions, apolipoproteins AI and B) were analyzed.
• Duplex ultrasonography was used to estimate carotid artery intimal wall thickness.
• Comparison was made between patients on carbamazepine, patients on valproate, and control groups.

Main Results:

• Carbamazepine was associated with increased total cholesterol, LDL-C, and HDL-C, and decreased ApoAI compared to controls.
• Valproate led to reduced total cholesterol, LDL-C, and ApoAI compared to controls.
• Carotid artery intimal wall thickness did not significantly differ across groups, despite altered lipid profiles.

Conclusions:

• Carbamazepine and valproate significantly alter lipid profiles in children with idiopathic epilepsy.
• Despite lipid changes, carotid artery intima-media thickness was not affected.
• Lowered apolipoprotein AI levels, particularly with carbamazepine, may suggest an increased risk for coronary heart disease.